Daily Stock Market Outlook Report by Imperial Money Pvt. Ltd. of 11th Feb, 2021. Download Free Report Now!!! Nifty opened with negative gap down today at 17,451.00 on 11th Feb 2022, index was very bearish and made a day low of 17,303 and closed negative at very important level 17,374.75. Resistance for nifty is 18,000 and support is 17,150 (Closing Basis). Index may test 19200 in coming days.

1. MARKET OUTLOOK REPORT
Figure. Nifty50 Intraday chart
Index Previous close Open High Low Close Change %
Nifty 50 17,605.85 17,451.00 17,454.75 17,303.00 17,374.75 1.31%
Sensex 58,926.03 58,447.15 58,447.15 57,914.10 58,152.92 1.31%
Nifty opened with negative
gap down today at
17,451.00 on 11th
Feb
2022, index was very
bearish and made a day
low of 17,303 and closed
negative at very important
level 17,374.75. Resistance
for nifty is 18,000 and
support is 17,150 (Closing
Basis). Index may test
19200 in coming days.
www.imperialfin.com wecare@imperialfin.com +91-9595889988
11th
FEB 2022

2. Sectorial Performance
0.84%
2.72%
0.75%
1.47%
1.27%
1.04%
0.59%
1.98%
0.59%
NIFTYFMCG
NIFTYIT
NIFTYPHARMA
NIFTYFINSERVICE
NIFTYBANK
NIFTYAUTO
NIFTYMEDIA
NIFTYREALTY
NIFTYMETAL
SECTORS CHANGE %
SECTORS CHANGE %
www.imperialfin.com wecare@imperialfin.com +91-9595889988
11th
FEB 2022

3. Top Trending News
 RICO AUTO INDUSTRIES:
Q3 CONS NET PROFIT 94M RUPEES VS 43.8M (YOY); 67M (QOQ) || Q3 REVENUE 4.73B RUPEES VS 4.5B (YOY); 4.77B
(QOQ).
 GODREJ INDUSTRIES:
Q3 EBITDA 2.4B RUPEES VS 923M (YOY) || Q3 EBITDA MARGIN 6.94% VS 3.92% (YOY).
 HUDCO:
Q3 REVENUE 17B RUPEES VS 18.34B (YOY); 17.21B (QOQ)
 MOTHERSON SUMI:
Q3 EBITDA 9.8B RUPEES VS 17.9B (YOY) || Q3 EBITDA MARGIN 6.06% VS 10.51% (YOY)
 STRIDES PHARMA:
CO UPDATED REGARDING SCHEME OF AMALGAMATION FOR MERGER OF VIVIMED LIFE SCIENCES PRIVATE LTD, A
WHOLLY OWNED SUBSIDIARY, WITH THE CO
 CAMS:
CO APPROVED DIVIDEND OF RUPEES 10.75/ SHARE
11th
FEB 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

4. 2.56%
2.29%
1.75%
1.26%
1.03%
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
GLAND AUROPHARMA IOC INDIGO INDUSINDBK
TOP GAINERS
5.99%
5.03%
3.65% 3.30% 3.29%
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
7.00%
NAUKRI LTI HAVELLS GRASIM GODREJCP
TOP LOSERS
Stocks in Action
www.imperialfin.com wecare@imperialfin.com +91-9595889988
11th
FEB 2022

5. Corporate Actions
 BALRAMCHIN (Interim Dividend Rs. 2.5 per share on 11th
Feb)
 BLS (Interim Dividend Rs. 1 per share on 11th
Feb)
FII/DII/FPI ACTION IN CAPITAL MARKET
Category Date Buy Value Sell Value Net Value
DII 10 Feb 2021 7853.15 cr 5125.92 cr 2727.23 cr
FII/FPI 10 Feb 2021 8660.61 cr 10393.19 cr -1732.58 cr
 The following is combined Domestic Institutional Investors trading data across NSE, BSE and MSEI
collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System.
11th
FEB 2022
www.imperialfin.com wecare@imperialfin.com +91-9595889988

6. SYMPHONY. Sector:ConsumerDurables.
Important Parameter
MARKET CAP P/B EPS BOOK VALUE PE ROE ROCE
6,977.16 CR 8.73 16.72 114.21 59.63 15.94% 20.92%
FUNDAMENTALS.
 Company has been maintaining healthy ROE of 20.01% over the past 3 years.
 Company has been maintaining healthy ROCE of 26.50% over the past 3 years.
 Company is virtually debt free.
 Company has a healthy Interest coverage ratio of 508.34.
Stock Entry price Positional
target
SYMPHONY 990 1250
www.imperialfin.com wecare@imperialfin.com +91-9595889988
11th
FEB 2022

7. Disclaimer
This document has been prepared for IMPERIAL MONEY PVT. LTD. by Mr. Praveen Dubey NISM (201800048686) is a Research Consultant for Imperial Money Pvt. Ltd. This Market Outlook is
intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any
review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. Imperial Money Pvt. Ltd. Does not carry any responsibility in case to whomsoever using the information of this newsletter content and data
www.imperialfin.com wecare@imperialfin.com +91-9595889988
11th
FEB 2022